Huijie Yang

1.1k total citations
40 papers, 711 citations indexed

About

Huijie Yang is a scholar working on Molecular Biology, Oncology and Cell Biology. According to data from OpenAlex, Huijie Yang has authored 40 papers receiving a total of 711 indexed citations (citations by other indexed papers that have themselves been cited), including 29 papers in Molecular Biology, 20 papers in Oncology and 10 papers in Cell Biology. Recurrent topics in Huijie Yang's work include Ubiquitin and proteasome pathways (18 papers), Cancer-related Molecular Pathways (11 papers) and Hippo pathway signaling and YAP/TAZ (10 papers). Huijie Yang is often cited by papers focused on Ubiquitin and proteasome pathways (18 papers), Cancer-related Molecular Pathways (11 papers) and Hippo pathway signaling and YAP/TAZ (10 papers). Huijie Yang collaborates with scholars based in China, United States and Australia. Huijie Yang's co-authors include Ting Zhuang, Jian Zhu, Hui Wang, Zhongbo Li, Juntao Xu, Xiumin Li, Min Xue, Kun Mu, Peng Su and Xin Li and has published in prestigious journals such as Nature Communications, PLoS ONE and Cancer Research.

In The Last Decade

Huijie Yang

37 papers receiving 708 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Huijie Yang China 15 501 207 155 111 94 40 711
Yongping Cui China 20 640 1.3× 235 1.1× 191 1.2× 170 1.5× 89 0.9× 42 891
Kyoung Eun Baek South Korea 13 432 0.9× 218 1.1× 109 0.7× 75 0.7× 69 0.7× 18 633
Peter Sicinski United States 9 457 0.9× 262 1.3× 112 0.7× 113 1.0× 89 0.9× 9 680
Yong‐Chuan Wong Hong Kong 17 659 1.3× 272 1.3× 220 1.4× 138 1.2× 136 1.4× 27 945
Xiaobo Cui China 18 574 1.1× 210 1.0× 319 2.1× 58 0.5× 66 0.7× 49 864
Wuguo Li China 16 569 1.1× 192 0.9× 272 1.8× 45 0.4× 78 0.8× 31 842
Núria Eritja Spain 18 449 0.9× 191 0.9× 202 1.3× 25 0.2× 63 0.7× 40 768
Maria Grazia Prisco Italy 16 310 0.6× 316 1.5× 117 0.8× 45 0.4× 79 0.8× 22 761
Hyuk Moon South Korea 14 500 1.0× 155 0.7× 191 1.2× 123 1.1× 82 0.9× 24 809
Dong Hoon Shin South Korea 16 491 1.0× 271 1.3× 311 2.0× 57 0.5× 152 1.6× 40 830

Countries citing papers authored by Huijie Yang

Since Specialization
Citations

This map shows the geographic impact of Huijie Yang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Huijie Yang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Huijie Yang more than expected).

Fields of papers citing papers by Huijie Yang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Huijie Yang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Huijie Yang. The network helps show where Huijie Yang may publish in the future.

Co-authorship network of co-authors of Huijie Yang

This figure shows the co-authorship network connecting the top 25 collaborators of Huijie Yang. A scholar is included among the top collaborators of Huijie Yang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Huijie Yang. Huijie Yang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Yang, Huijie, Jin Cui, Peng Su, et al.. (2025). Oxytocin Receptor Regulates the Hippo/YAP Axis to Drive Hepatocarcinogenesis. Cancer Research. 85(19). 3752–3770.
2.
Yang, Huijie, Huijie Yang, Wenbo Ma, et al.. (2025). Antithrombotic Effect of Ginkgo Biloba Extract: A Study Based on Network Pharmacological Analysis and In vivo Experiments. Nigerian Journal of Clinical Practice. 28(5). 624–632.
3.
Zhuang, Ting Ting, Shuqing Zhang, Dongyi Liu, et al.. (2024). USP36 promotes tumorigenesis and tamoxifen resistance in breast cancer by deubiquitinating and stabilizing ERα. Journal of Experimental & Clinical Cancer Research. 43(1). 249–249. 5 indexed citations
4.
Yang, Huijie, Hongbo Wang, Shuanglin Qin, et al.. (2024). Tryptanthrin suppresses multiple inflammasome activation to regulate NASH progression by targeting ASC protein. Phytomedicine. 131. 155758–155758. 6 indexed citations
5.
Su, Peng, Yanan Sun, Xin Li, et al.. (2024). YAP represses the TEAD–NF-κB complex and inhibits the growth of clear cell renal cell carcinoma. Science Signaling. 17(843). eadk0231–eadk0231. 6 indexed citations
6.
Yu, Pengfei, Wenyan Wang, Chunjie Sha, et al.. (2023). A novel scaffold long-acting selective estrogen receptor antagonist and degrader with superior preclinical profile against ER+ breast cancer. European Journal of Medicinal Chemistry. 264. 115934–115934. 6 indexed citations
7.
Xiao, Yang, Dehai Wang, Huijie Yang, et al.. (2023). PSMD14 stabilizes estrogen signaling and facilitates breast cancer progression via deubiquitinating ERα. Oncogene. 43(4). 248–264. 17 indexed citations
8.
Li, Quanhui, Xin Li, Zhongbo Li, et al.. (2023). USP1 modulates hepatocellular carcinoma progression via the Hippo/TAZ axis. Cell Death and Disease. 14(4). 264–264. 22 indexed citations
9.
Wang, Tianshi, Dehai Wang, Yanan Sun, et al.. (2023). Regulation of the Hippo/YAP axis by CXCR7 in the tumorigenesis of gastric cancer. Journal of Experimental & Clinical Cancer Research. 42(1). 297–297. 14 indexed citations
10.
Niu, Zhiguo, Fengzhe Chen, Huijie Yang, et al.. (2022). RBCK1 regulates the progression of ER-positive breast cancer through the HIF1α signaling. Cell Death and Disease. 13(12). 1023–1023. 6 indexed citations
11.
Zhuang, Ting, Beibei Wang, Le Wu, et al.. (2022). TRIM3 facilitates estrogen signaling and modulates breast cancer cell progression. Cell Communication and Signaling. 20(1). 45–45. 9 indexed citations
12.
Li, Xin, Zhiguo Niu, Chen Sun, et al.. (2022). Regulation of P53 signaling in breast cancer by the E3 ubiquitin ligase RNF187. Cell Death and Disease. 13(2). 149–149. 9 indexed citations
13.
Yuan, Lei, Xin Li, Huijie Yang, & Huixiang Li. (2022). The ubiquitin ligase RNF2 stabilizes ERα and modulates breast cancer progression. Human Cell. 36(1). 353–365. 5 indexed citations
14.
Shang, Man, Huijie Yang, Ran Yang, et al.. (2021). The folate cycle enzyme MTHFD2 induces cancer immune evasion through PD-L1 up-regulation. Nature Communications. 12(1). 1940–1940. 114 indexed citations
15.
Niu, Zhiguo, Xin Li, Shuxiao Dong, et al.. (2021). The E3 Ubiquitin Ligase HOIP inhibits Cancer Cell Apoptosis via modulating PTEN stability. Journal of Cancer. 12(21). 6553–6562. 7 indexed citations
16.
Zhou, Rui, Peishan Qiu, Haizhou Wang, et al.. (2021). Identification of microRNA-16-5p and microRNA-21-5p in feces as potential noninvasive biomarkers for inflammatory bowel disease. Aging. 13(3). 4634–4646. 28 indexed citations
17.
Xue, Min, Kai Zhang, Kun Mu, et al.. (2019). Regulation of estrogen signaling and breast cancer proliferation by an ubiquitin ligase TRIM56. Oncogenesis. 8(5). 30–30. 74 indexed citations
18.
19.
Yang, Huijie, Sifan Yu, Weilong Wang, et al.. (2017). SHARPIN Facilitates p53 Degradation in Breast Cancer Cells. Neoplasia. 19(2). 84–92. 37 indexed citations
20.
Zhu, Jian, et al.. (2016). Atypical ubiquitin ligase RNF31: the nuclear factor modulator in breast cancer progression. BMC Cancer. 16(1). 538–538. 29 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Yongping Cui Breakdown of academic impact, for papers by Kyoung Eun Baek Breakdown of academic impact, for papers by Peter Sicinski Breakdown of academic impact, for papers by Yong‐Chuan Wong Breakdown of academic impact, for papers by Xiaobo Cui Breakdown of academic impact, for papers by Wuguo Li Breakdown of academic impact, for papers by Núria Eritja Breakdown of academic impact, for papers by Maria Grazia Prisco Breakdown of academic impact, for papers by Hyuk Moon Breakdown of academic impact, for papers by Dong Hoon Shin
Rankless by CCL
2026